These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 31669605)
1. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals. Wen J; Batabyal D; Knutson N; Lord H; Wikström M J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605 [TBL] [Abstract][Full Text] [Related]
2. Use of the 2D Hwang TL; Batabyal D; Knutson N; Wikström M Molecules; 2021 May; 26(9):. PubMed ID: 34063095 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches. Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY MAbs; 2024; 16(1):2292688. PubMed ID: 38117548 [TBL] [Abstract][Full Text] [Related]
4. Assessing the Utility of Circular Dichroism and FTIR Spectroscopy in Monoclonal-Antibody Comparability Studies. Lin JC; Glover ZK; Sreedhara A J Pharm Sci; 2015 Dec; 104(12):4459-4466. PubMed ID: 26505267 [TBL] [Abstract][Full Text] [Related]
5. Automated, High-Throughput Infrared Spectroscopy for Secondary Structure Analysis of Protein Biopharmaceuticals. Liu LL; Wang L; Zonderman J; Rouse JC; Kim HY J Pharm Sci; 2020 Oct; 109(10):3223-3230. PubMed ID: 32758548 [TBL] [Abstract][Full Text] [Related]
6. Determining Spectroscopic Quantitation Limits for Misfolded Structures. Kendrick BS; Gabrielson JP; Solsberg CW; Ma E; Wang L J Pharm Sci; 2020 Jan; 109(1):933-936. PubMed ID: 31521643 [TBL] [Abstract][Full Text] [Related]
7. Characterization of protein higher order structure using vibrational circular dichroism spectroscopy. Nagarkar RP; Murphy BM; Yu X; Manning MC; Al-Azzam WA Curr Pharm Biotechnol; 2013; 14(2):199-208. PubMed ID: 23167760 [TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization of Met-G-CSF: effects of different site-specific mono-pegylations on protein stability and aggregation. Natalello A; Ami D; Collini M; D'Alfonso L; Chirico G; Tonon G; Scaramuzza S; Schrepfer R; Doglia SM PLoS One; 2012; 7(8):e42511. PubMed ID: 22905140 [TBL] [Abstract][Full Text] [Related]
15. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability. Harn N; Allan C; Oliver C; Middaugh CR J Pharm Sci; 2007 Mar; 96(3):532-46. PubMed ID: 17083094 [TBL] [Abstract][Full Text] [Related]
16. Technical decision-making with higher order structure data: specific binding of a nonionic detergent perturbs higher order structure of a therapeutic monoclonal antibody. Budyak IL; Doyle BL; Weiss WF J Pharm Sci; 2015 Apr; 104(4):1543-7. PubMed ID: 25545760 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Higher Order Structural Changes of a Thermally Stressed Monoclonal Antibody via Mass Spectrometry Footprinting and Other Biophysical Approaches. Lin Y; Moyle AB; Beaumont VA; Liu LL; Polleck S; Liu H; Shi H; Rouse JC; Kim HY; Zhang Y; Gross ML Anal Chem; 2023 Nov; 95(46):16840-16849. PubMed ID: 37933954 [TBL] [Abstract][Full Text] [Related]
18. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308 [TBL] [Abstract][Full Text] [Related]
19. What NMR can do in the biopharmaceutical industry. Kiss R; Fizil Á; Szántay C J Pharm Biomed Anal; 2018 Jan; 147():367-377. PubMed ID: 28760370 [TBL] [Abstract][Full Text] [Related]
20. Higher Order Structure Characterization of Two Interdomain Disulfide Bond Variants of a Bispecific Monoclonal Antibody. Budyak IL; Huang L; Dukor RK J Pharm Sci; 2024 May; ():. PubMed ID: 38750935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]